MEMS at the Forefront of SARS-CoV-2 Testing

MEMS at the Forefront of SARS-CoV-2 Testing

On Saturday, March, 21, 2020 the U.S. Food and Drug Administration (FDA) gave emergency authorization to Cepheid, a California company, to sell a new test for rapid detection of the pandemic coronavirus SARS-CoV-2, which causes COVID-19. Cepheid’s Xpert® Xpress SARS-CoV-2 test gives healthcare workers results in just 45 minutes, with less than a minute of hands-on time for sample preparation.

Read full article

Back to news list >

As you navigate through our site, certain cookies may be stored in or retrieved from your browser. This information may relate to you, your preferences or your device and is primarily used to ensure that the site functions correctly. The information does not identify you directly, but may help you benefit from an enhanced Web experience. Because we respect your privacy, we give you the opportunity not to allow these cookies.

Close Popup
Privacy Settings saved!
Privacy settings

As you navigate through our site, certain cookies may be stored in or retrieved from your browser. This information may relate to you, your preferences or your device and is primarily used to ensure that the site functions correctly. The information does not identify you directly, but may help you benefit from an enhanced Web experience. Because we respect your privacy, we give you the opportunity not to allow these cookies.


Google Analytics
We track anonymized user information to improve our website.
  • _ga
  • _gid
  • _gat

Decline
Save
Accept